{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,21]],"date-time":"2026-11-21T07:37:15Z","timestamp":1795246635971,"version":"4.10.3"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,12,15]],"date-time":"2022-12-15T00:00:00Z","timestamp":1671062400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,12,15]],"date-time":"2022-12-15T00:00:00Z","timestamp":1671062400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["21835007"],"award-info":[{"award-number":["21835007"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Distressing and lethal cardiotoxicity is one of the major severe side effects of using anthracycline drugs such as doxorubicin for cancer chemotherapy. The currently available strategy to counteract these side effects relies on the administration of cardioprotective agents such as Dexrazoxane, which unfortunately has unsatisfactory efficacy and produces secondary myelosuppression. In the present work, aiming to target the characteristic ferrous iron overload in the doxorubicin-contaminated cardiac microenvironment, a biocompatible nanomedicine prepared by the polyvinylpyrrolidone-directed assembly of magnesium hexacyanoferrate nanocatalysts is designed and constructed for highly efficient intracellular ferrous ion capture and antioxidation. The synthesized magnesium hexacyanoferrate nanocatalysts display prominent superoxide radical dismutation and catalytic H<jats:sub>2<\/jats:sub>O<jats:sub>2<\/jats:sub> decomposition activities to eliminate cytotoxic radical species. Excellent in vitro and in vivo cardioprotection from these magnesium hexacyanoferrate nanocatalysts are demonstrated, and the underlying intracellular ferrous ion traffic regulation mechanism has been explored in detail. The marked cardioprotective effect and biocompatibility render these magnesium hexacyanoferrate nanocatalysts to be highly promising and clinically transformable cardioprotective agents that can be employed during cancer treatment.<\/jats:p>","DOI":"10.1038\/s41467-022-35503-y","type":"journal-article","created":{"date-parts":[[2022,12,15]],"date-time":"2022-12-15T18:11:30Z","timestamp":1671127890000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":57,"title":["Magnesium hexacyanoferrate nanocatalysts attenuate chemodrug-induced cardiotoxicity through an anti-apoptosis mechanism driven by modulation of ferrous iron"],"prefix":"10.1038","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5717-1845","authenticated-orcid":false,"given":"Minfeng","family":"Huo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhimin","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liying","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linlin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haiyan","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8206-3325","authenticated-orcid":false,"given":"Yu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7681-1043","authenticated-orcid":false,"given":"Ping","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8790-195X","authenticated-orcid":false,"given":"Jianlin","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,12,15]]},"reference":[{"key":"35503_CR1","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1038\/s41583-019-0132-6","volume":"20","author":"DA Butterfield","year":"2019","unstructured":"Butterfield, D. A. & Halliwell, B. Oxidative stress, dysfunctional glucose metabolism and Alzheimer disease. Nat. Rev. Neurosci. 20, 148\u2013160 (2019).","journal-title":"Nat. Rev. Neurosci."},{"key":"35503_CR2","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1038\/s41577-020-0407-1","volume":"20","author":"M Laforge","year":"2020","unstructured":"Laforge, M. et al. Tissue damage from neutrophil-induced oxidative stress in COVID-19. Nat. Rev. Immunol. 20, 515\u2013516 (2020).","journal-title":"Nat. Rev. Immunol."},{"issue":"Suppl.","key":"35503_CR3","doi-asserted-by":"publisher","first-page":"S18","DOI":"10.1038\/nrn1434","volume":"10","author":"JK Andersen","year":"2004","unstructured":"Andersen, J. K. Oxidative stress in neurodegeneration: cause or consequence? Nat. Med. 10(Suppl.), S18\u2013S25 (2004).","journal-title":"Nat. Med."},{"key":"35503_CR4","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1038\/nature05292","volume":"443","author":"MT Lin","year":"2006","unstructured":"Lin, M. T. & Beal, M. F. Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases. Nature 443, 787\u2013795 (2006).","journal-title":"Nature"},{"key":"35503_CR5","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1038\/ncpneph0283","volume":"2","author":"ND Vaziri","year":"2006","unstructured":"Vaziri, N. D. & Rodriguez-Iturbe, B. Mechanisms of disease: oxidative stress and inflammation in the pathogenesis of hypertension. Nat. Clin. Pract. Nephrol. 2, 582\u2013593 (2006).","journal-title":"Nat. Clin. Pract. Nephrol."},{"key":"35503_CR6","doi-asserted-by":"publisher","first-page":"2026","DOI":"10.1021\/acs.accounts.9b00248","volume":"52","author":"Y Liu","year":"2019","unstructured":"Liu, Y. et al. Metal ions in Alzheimer\u2019s disease: a key role or not? Acc. Chem. Res. 52, 2026\u20132035 (2019).","journal-title":"Acc. Chem. Res."},{"key":"35503_CR7","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1038\/nrcardio.2015.65","volume":"12","author":"MS Ewer","year":"2015","unstructured":"Ewer, M. S. & Ewer, S. M. Cardiotoxicity of anticancer treatments. Nat. Rev. Cardiol. 12, 547\u2013558 (2015).","journal-title":"Nat. Rev. Cardiol."},{"key":"35503_CR8","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-019-1901-x","volume":"10","author":"JA Pan","year":"2019","unstructured":"Pan, J. A. et al. miR-146a attenuates apoptosis and modulates autophagy by targeting TAF9b\/P53 pathway in doxorubicin-induced cardiotoxicity. Cell Death Dis. 10, 668 (2019).","journal-title":"Cell Death Dis."},{"key":"35503_CR9","doi-asserted-by":"publisher","first-page":"1981","DOI":"10.1161\/CIRCULATIONAHA.114.013777","volume":"131","author":"D Cardinale","year":"2015","unstructured":"Cardinale, D. et al. Early detection of anthracycline cardiotoxicity and improvement with heart failure therapy. Circulation 131, 1981\u20131988 (2015).","journal-title":"Circulation"},{"key":"35503_CR10","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1126\/science.369.6499.18","volume":"369","author":"J Kaiser","year":"2020","unstructured":"Kaiser, J. A colorful chemotherapy agent could be made less toxic. Science 369, 18 (2020).","journal-title":"Science"},{"key":"35503_CR11","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1056\/NEJM199809243391307","volume":"339","author":"PK Singal","year":"1998","unstructured":"Singal, P. K. & Iliskovic, N. Doxorubicin-induced cardiomyopathy. N. Engl. J. Med. 339, 900\u2013905 (1998).","journal-title":"N. Engl. J. Med."},{"key":"35503_CR12","doi-asserted-by":"publisher","first-page":"2672","DOI":"10.1073\/pnas.1821022116","volume":"116","author":"X Fang","year":"2019","unstructured":"Fang, X. et al. Ferroptosis as a target for protection against cardiomyopathy. Proc. Natl Acad. Sci. USA 116, 2672\u20132680 (2019).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"35503_CR13","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1038\/s41422-019-0150-y","volume":"29","author":"M Conrad","year":"2019","unstructured":"Conrad, M. & Proneth, B. Broken hearts: Iron overload, ferroptosis and cardiomyopathy. Cell Res. 29, 263\u2013264 (2019).","journal-title":"Cell Res."},{"key":"35503_CR14","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-13143-z","volume":"10","author":"H Kang","year":"2019","unstructured":"Kang, H. et al. Renal clearable nanochelators for iron overload therapy. Nat. Commun. 10, 5134 (2019).","journal-title":"Nat. Commun."},{"key":"35503_CR15","doi-asserted-by":"publisher","first-page":"eabb2695","DOI":"10.1126\/sciadv.abb2695","volume":"6","author":"Y Liu","year":"2020","unstructured":"Liu, Y. et al. Integrated cascade nanozyme catalyzes in vivo ROS scavenging for anti-inflammatory therapy. Sci. Adv. 6, eabb2695 (2020).","journal-title":"Sci. Adv."},{"key":"35503_CR16","doi-asserted-by":"publisher","first-page":"eaay9751","DOI":"10.1126\/sciadv.aay9751","volume":"6","author":"L He","year":"2020","unstructured":"He, L. et al. Highly bioactive zeolitic imidazolate framework-8-capped nanotherapeutics for efficient reversal of reperfusion-induced injury in ischemic stroke. Sci. Adv. 6, eaay9751 (2020).","journal-title":"Sci. Adv."},{"key":"35503_CR17","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-16544-7","volume":"11","author":"T Liu","year":"2020","unstructured":"Liu, T. et al. Ultrasmall copper-based nanoparticles for reactive oxygen species scavenging and alleviation of inflammation related diseases. Nat. Commun. 11, 2788 (2020).","journal-title":"Nat. Commun."},{"key":"35503_CR18","doi-asserted-by":"publisher","first-page":"5177","DOI":"10.1021\/jacs.9b12873","volume":"142","author":"Y Sang","year":"2020","unstructured":"Sang, Y. et al. Bioinspired construction of a nanozyme-based H2O2 homeostasis disruptor for intensive chemodynamic therapy. J. Am. Chem. Soc. 142, 5177\u20135183 (2020).","journal-title":"J. Am. Chem. Soc."},{"key":"35503_CR19","doi-asserted-by":"publisher","first-page":"2007130","DOI":"10.1002\/adfm.202007130","volume":"31","author":"J Xi","year":"2020","unstructured":"Xi, J. et al. A nanozyme-based artificial peroxisome ameliorates hyperuricemia and ischemic stroke. Adv. Funct. Mater. 31, 2007130 (2020).","journal-title":"Adv. Funct. Mater."},{"key":"35503_CR20","doi-asserted-by":"publisher","first-page":"1902123","DOI":"10.1002\/smll.201902123","volume":"16","author":"S Lin","year":"2019","unstructured":"Lin, S. et al. Copper tannic acid coordination nanosheet: a potent nanozyme for scavenging ROS from cigarette smoke. Small 16, 1902123 (2019).","journal-title":"Small"},{"key":"35503_CR21","doi-asserted-by":"publisher","first-page":"e2000542","DOI":"10.1002\/adma.202000542","volume":"32","author":"W Wu","year":"2020","unstructured":"Wu, W. et al. Copper-enriched prussian blue nanomedicine for in situ disulfiram toxification and photothermal antitumor amplification. Adv. Mater. 32, e2000542 (2020).","journal-title":"Adv. Mater."},{"key":"35503_CR22","doi-asserted-by":"publisher","first-page":"e2001452","DOI":"10.1002\/adma.202001452","volume":"32","author":"Y Chen","year":"2020","unstructured":"Chen, Y. et al. Tumor-microenvironment-triggered ion exchange of a metal-organic framework hybrid for multimodal imaging and synergistic therapy of tumors. Adv. Mater. 32, e2001452 (2020).","journal-title":"Adv. Mater."},{"key":"35503_CR23","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1021\/jacs.8b11856","volume":"141","author":"C Hao","year":"2019","unstructured":"Hao, C. et al. Chiral molecule-mediated porous CuxO nanoparticle clusters with antioxidation activity for ameliorating Parkinson\u2019s disease. J. Am. Chem. Soc. 141, 1091\u20131099 (2019).","journal-title":"J. Am. Chem. Soc."},{"key":"35503_CR24","doi-asserted-by":"publisher","first-page":"5860","DOI":"10.1021\/jacs.5b12070","volume":"138","author":"W Zhang","year":"2016","unstructured":"Zhang, W. et al. Prussian blue nanoparticles as multienzyme mimetics and reactive oxygen species scavengers. J. Am. Chem. Soc. 138, 5860\u20135865 (2016).","journal-title":"J. Am. Chem. Soc."},{"key":"35503_CR25","doi-asserted-by":"publisher","first-page":"119678","DOI":"10.1016\/j.biomaterials.2019.119678","volume":"231","author":"X Cai","year":"2020","unstructured":"Cai, X. et al. Self-assembly hollow manganese Prussian white nanocapsules attenuate Tau-related neuropathology and cognitive decline. Biomaterials 231, 119678 (2020).","journal-title":"Biomaterials"},{"key":"35503_CR26","doi-asserted-by":"publisher","first-page":"2214","DOI":"10.1002\/anie.201713177","volume":"57","author":"Z Wang","year":"2018","unstructured":"Wang, Z. et al. KCa(H2O)2[Fe(III)(CN)6]H2O nanoparticles as an antimicrobial agent against Staphylococcus aureus. Angew. Chem. Int. Ed. 57, 2214\u20132218 (2018).","journal-title":"Angew. Chem. Int. Ed."},{"key":"35503_CR27","doi-asserted-by":"publisher","first-page":"35372","DOI":"10.1039\/C9RA07490B","volume":"9","author":"F Wang","year":"2019","unstructured":"Wang, F. et al. Synthesis, structure, magnetism and photocatalysis of \u03b1-Fe2O3 nanosnowflakes. RSC Adv. 9, 35372\u201335383 (2019).","journal-title":"RSC Adv."},{"key":"35503_CR28","doi-asserted-by":"publisher","first-page":"2770","DOI":"10.1039\/C4TA05250A","volume":"3","author":"M Luo","year":"2015","unstructured":"Luo, M. et al. Facile removal of polyvinylpyrrolidone (PVP) adsorbates from Pt alloy nanoparticles. J. Mater. Chem. A 3, 2770\u20132775 (2015).","journal-title":"J. Mater. Chem. A"},{"key":"35503_CR29","doi-asserted-by":"publisher","first-page":"2008989","DOI":"10.1002\/adfm.202008989","volume":"31","author":"H Zhang","year":"2020","unstructured":"Zhang, H. et al. Pd Ion-exchange and ammonia etching of a prussian blue analogue to produce a high-performance water-splitting catalyst. Adv. Funct. Mater. 31, 2008989 (2020).","journal-title":"Adv. Funct. Mater."},{"key":"35503_CR30","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1021\/acs.inorgchem.0c03249","volume":"60","author":"J Zimara","year":"2021","unstructured":"Zimara, J. et al. Time-resolved spectroscopy of photoinduced electron transfer in dinuclear and tetranuclear Fe\/Co Prussian Blue analogues. Inorg. Chem. 60, 449\u2013459 (2021).","journal-title":"Inorg. Chem."},{"key":"35503_CR31","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1038\/s41580-020-0230-3","volume":"21","author":"H Sies","year":"2020","unstructured":"Sies, H. & Jones, D. P. Reactive oxygen species (ROS) as pleiotropic physiological signalling agents. Nat. Rev. Mol. Cell Biol. 21, 363\u2013383 (2020).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"35503_CR32","doi-asserted-by":"publisher","first-page":"2177","DOI":"10.3390\/cells9102177","volume":"9","author":"M Dallons","year":"2020","unstructured":"Dallons, M. et al. GPR91 receptor mediates protection against doxorubicin-induced cardiotoxicity without altering its anticancer efficacy. An in vitro study on H9C2 cardiomyoblasts and breast cancer-derived MCF-7 cells. Cells 9, 2177 (2020).","journal-title":"Cells"},{"key":"35503_CR33","doi-asserted-by":"publisher","first-page":"79","DOI":"10.3389\/fphar.2020.00079","volume":"11","author":"M Dallons","year":"2020","unstructured":"Dallons, M. et al. New insights about doxorubicin- induced toxicity to cardiomyoblast- derived H9C2 cells and dexrazoxane cytoprotective effect: contribution of in vitro 1H-NMR metabonomics. Front. Pharmacol. 11, 79 (2020).","journal-title":"Front. Pharmacol."},{"key":"35503_CR34","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-021-03614-x","volume":"12","author":"E Christidi","year":"2021","unstructured":"Christidi, E. & Brunham, L. R. Regulated cell death pathways in doxorubicin-induced cardiotoxicity. Cell Death Dis. 12, 339 (2021).","journal-title":"Cell Death Dis."},{"key":"35503_CR35","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1038\/nri3863","volume":"15","author":"T Ganz","year":"2015","unstructured":"Ganz, T. & Nemeth, E. Iron homeostasis in host defence and inflammation. Nat. Rev. Immunol. 15, 500\u2013510 (2015).","journal-title":"Nat. Rev. Immunol."},{"key":"35503_CR36","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1038\/s41565-019-0406-1","volume":"14","author":"V Trujillo-Alonso","year":"2019","unstructured":"Trujillo-Alonso, V. et al. FDA-approved ferumoxytol displays anti-leukaemia efficacy against cells with low ferroportin levels. Nat. Nanotechnol. 14, 616\u2013622 (2019).","journal-title":"Nat. Nanotechnol."},{"key":"35503_CR37","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1038\/s41551-020-00637-1","volume":"4","author":"S Liu","year":"2020","unstructured":"Liu, S. et al. Treatment of infarcted heart tissue via the capture and local delivery of circulating exosomes through antibody-conjugated magnetic nanoparticles. Nat. Biomed. Eng. 4, 1063\u20131075 (2020).","journal-title":"Nat. Biomed. Eng."},{"key":"35503_CR38","doi-asserted-by":"publisher","first-page":"2663","DOI":"10.2217\/fon-2018-0210","volume":"14","author":"P Reichardt","year":"2018","unstructured":"Reichardt, P. et al. Risk\u2013benefit of dexrazoxane for preventing anthracycline-related cardiotoxicity: re-evaluating the European labeling. Future Oncol. 14, 2663\u20132676 (2018).","journal-title":"Future Oncol."},{"key":"35503_CR39","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1001\/jamacardio.2016.3841","volume":"2","author":"H Abdel-Qadir","year":"2017","unstructured":"Abdel-Qadir, H. et al. A population-based study of cardiovascular mortality following early-stage breast cancer. JAMA Cardiol. 2, 88\u201393 (2017).","journal-title":"JAMA Cardiol."},{"key":"35503_CR40","doi-asserted-by":"publisher","first-page":"109158","DOI":"10.1016\/j.ejrad.2020.109158","volume":"130","author":"R Cau","year":"2020","unstructured":"Cau, R. et al. Early diagnosis of chemotherapy-induced cardiotoxicity by cardiac MRI. Eur. J. Radiol. 130, 109158 (2020).","journal-title":"Eur. J. Radiol."},{"key":"35503_CR41","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1016\/j.ccl.2019.07.010","volume":"37","author":"S Shoukat","year":"2019","unstructured":"Shoukat, S., Zheng, D. & Yusuf, S. W. Cardiotoxicity related to radiation therapy. Cardiol. Clin. 37, 449\u2013458 (2019).","journal-title":"Cardiol. Clin."},{"key":"35503_CR42","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1007\/s11095-019-2745-x","volume":"37","author":"A Al Shoyaib","year":"2019","unstructured":"Al Shoyaib, A., Archie, S. R. & Karamyan, V. T. Intraperitoneal route of drug administration: should it be used in experimental animal studies? Pharm. Res. 37, 12 (2019).","journal-title":"Pharm. Res."},{"key":"35503_CR43","doi-asserted-by":"publisher","first-page":"15182","DOI":"10.1073\/pnas.1922072117","volume":"117","author":"X Qiao","year":"2020","unstructured":"Qiao, X. et al. Uncoupling DNA damage from chromatin damage to detoxify doxorubicin. Proc. Natl Acad. Sci. USA 117, 15182\u201315192 (2020).","journal-title":"Proc. Natl Acad. Sci. USA"}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-022-35503-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-022-35503-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-022-35503-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,15]],"date-time":"2022-12-15T20:11:21Z","timestamp":1671135081000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-022-35503-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,15]]},"references-count":43,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["35503"],"URL":"https:\/\/doi.org\/10.1038\/s41467-022-35503-y","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,15]]},"assertion":[{"value":"25 August 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 December 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 December 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"7778"}}